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High-temperature requirement protease A (HtrA) represents a family of serine proteases that play important roles in microbial
biology. Unlike the genomes of most organisms, that of Borrelia burgdorferi notably encodes a single HtrA gene product, termed
BbHtrA. Previous studies identified a few substrates of BbHtrA; however, their physiological relevance could not be ascertained,
as targeted deletion of the gene has not been successful. Here we show that BbhtrA transcripts are induced during spirochete
growth either in the stationary phase or at elevated temperature. Successful generation of a BbhtrA deletion mutant and restora-
tion by genetic complementation suggest a nonessential role for this protease in microbial viability; however, its remarkable
growth, morphological, and structural defects during cultivation at 37°C confirm a high-temperature requirement for protease
activation and function. The BbhtrA-deficient spirochetes were unable to establish infection of mice, as evidenced by assessment
of culture, PCR, and serology. We show that transcript abundance as well as proteolytic processing of a borrelial protein re-
quired for cell fission and infectivity, BB0323, is impaired in BbhtrAmutants grown at 37°C, which likely contributed to their
inability to survive in a mammalian host. Together, these results demonstrate the physiological relevance of a unique tempera-
ture-regulated borrelial protease, BbHtrA, which further enlightens our knowledge of intriguing aspects of spirochete biology
and infectivity.
Lyme disease is a common vector-borne infectious disease inthe Northern Hemisphere, posing a serious health threat to
humans and animals (1–3). Newly revised estimates from the
Centers for Disease Control and Prevention suggest that there are
likely to be over 300,000 new cases per year in the United States
alone, and a vaccine to prevent human infection is currently un-
available. The disease can be transmitted via the bite of the in-
fected arthropod vector, the Ixodes scapularis tick, harboring the
spirochete pathogen Borrelia burgdorferi, often resulting in serious
illness in susceptible hosts (2, 3). While most Lyme disease cases
can be treated with an antibiotic, a minority of patients will have
persistent or relapsing nonobjective symptoms that vary in inten-
sity, are nonresponsive to further antibiotic therapy, and are col-
lectively termed chronic Lyme disease or posttreatment Lyme dis-
ease syndrome, the underlying mechanism and pathogenesis of
which remain highly controversial (4). Detection of early Lyme
disease, when antibiotic treatment is most effective, also remains
challenging, as the infection reflects many nonspecific symptoms
that are shared by many other febrile or influenza-like diseases (5,
6). Thus, the development of efficient diagnostics, vaccines, or
new effective drugs is a high-priority goal that requires a thorough
understanding of the unusual biology and infection process of this
pathogen.
The pathogen of Lyme disease exhibits evolutionary diver-
gence from other bacteria, even related pathogenic spirochetes,
and persists in a complex enzootic infection cycle. Thus, it is
perhaps not surprising that a great majority of the proteins
encoded by the B. burgdorferi genome have unknown functions
relevant only to the special biology of spirochetes (7–10). The
genome also shows notable structural and functional redun-
dancy, reflected by the presence of a significant number of
paralogous gene clusters, as well as many genes that are not
required for infectivity in mammals and/or ticks (2, 7–11).
Although various aspects of spirochete infectivity are well stud-
ied, many questions remain unanswered, particularly regard-
ing mechanisms that dictate the remarkable ability of the
pathogen to adapt to and persist in diverse hosts, including the
multifactorial processes that influence the inflammatory out-
come in susceptible hosts. Maintenance of B. burgdorferi in the
enzootic cycle requires successful persistence in the arthropod
and reservoir hosts, as well as efficient transmission between
the tick and its host (11). Therefore, in order to survive transi-
tions between diverse vector and host environments, B. burg-
dorferi must be able not only to detect changes in its environ-
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ment but also to generate suitable response to these changes. As
a result, gene products playing roles in adaptation to cellular
stress, including temperature, oxidative stress, pH, etc., must
be critical for the life cycle of the pathogen.
The high-temperature requirement A (HtrA) family of serine
proteases can be found in all forms of life, from prokaryotes to
mammals (12–14). HtrA proteases function primarily in protein
homeostasis and quality control, acting as proteases and chaper-
ones that stabilize specific proteins and modulate signaling path-
ways (12). Similarly, HtrA proteases have been reported to play an
essential role in the virulence of a number of pathogens, such as
Mycobacterium tuberculosis (15), Salmonella enterica (16, 17), He-
licobacter pylori (18), Streptococcus pneumoniae (19), Bacillus an-
thracis (20), and Staphylococcus aureus (21), and have also been
associated with several human diseases (21–23). While the pre-
dominant mechanism of loss of virulence lies in the substrate pro-
teins that are stabilized or processed by HtrA, a direct role for
HtrA in pathogen invasiveness has also been reported (18, 24).
The unique feature of HtrA is the presence of a protease domain
containing a highly conserved active-site catalytic triad (Ser-His-
Asp) and one or two PDZ domains toward the carboxyl terminus
(12, 13). The overall structures of HtrA proteases are similar; how-
ever, their functions and substrates are remarkably quite diverse.
While the common structural building unit is a trimer, upon rec-
ognizing substrates, HtrA monomers form higher-order oligo-
meric structures ranging from 6- to 24-mers (13, 25). These oli-
gomers form a cage with the proteolytically active site facing the
interior and the PDZ domains protruding outside. The involve-
ment of HtrA proteases in the processing of critical substrates
supporting microbial virulence, as well as their pathogen-specific
diversification, makes them an attractive target for therapeutic
intervention (23, 26).
Most of the metazoan or bacterial genomes encode multiple
HtrA homologs that are implicated in diverse physiological func-
tions (27). Notably, the genome of B. burgdorferi contains a single
htrA gene (locus bb0104) (28) that encodes BbHtrA, which has
been biochemically characterized and shown to possess con-
served, catalytic, serine-dependent proteolytic activity (28–32).
BbHtrA possesses an N-terminal signal peptide sequence, and
apart from its periplasmic and cytosolic fractions, it also localizes
in outer membrane vesicles and is secreted into growth media (29,
32). Few interacting partners and substrates of BbHtrA have also
been identified (28–32). For instance, BbHtrA has been shown to
cleave basic membrane protein D (BmpD) and chemotaxis signal
transduction phosphatase (CheX) (29). In addition, previous in
vitro studies have suggested that BbHtrA also cleaves BB0323 (28),
a borrelial protein important for cell growth, fission, and infection
(33, 34). Also, it has been shown that BbHtrA degrades the extra-
cellular matrix proteoglycan aggrecan, fibronectin, and numerous
other proteoglycans (32), and recently, the inhibition of this pro-
tease by zinc has been reported (35). However, despite these sem-
inal studies, the precise biological significance of BbHtrA remains
enigmatic, as efforts aimed at targeted deletion of the gene have
thus far not been successful (28–30). Here we report the successful
generation and characterization of a BbhtrA deletion mutant and
complemented isolates of an infectious isolate of B. burgdorferi,
which highlight a critical role for this protease in spirochete biol-
ogy and infectivity.
MATERIALS AND METHODS
B. burgdorferi strains and mice. Low-passage-number B. burgdorferi
strain 297 clone AH130 (36) was used in this study. Bacteria were culti-
vated in Barbour-Stoenner-Kelly II (BSK-II) medium at 34°C or 37°C.
BbhtrA mutant strains were maintained under antibiotic selection with
gentamicin (40 mg/ml). Four- to 6-week-old C3H/HeN mice were pur-
chased from the National Institutes of Health. All animal experiments
were performed in accordance with the guidelines of the Institutional
Animal Care and Use Committee and Institutional Biosafety Committee
of the University of Maryland, College Park.
Generation of BbhtrA deletion mutant and complemented strains.
BbhtrA-deficient B. burgdorferi clones were generated by homologous re-
combination, replacing the bb0104 gene with a gentamicin resistance cas-
sette. Briefly, the 1.5-kb upstream region and the 1.5-kb downstream re-
gion of bb0104 (BbhtrA) were PCR amplified from the B. burgdorferi
genomic DNA with the primers indicated in Table S1 in the supplemental
material. The DNA amplicons were then cloned upstream and down-
stream of a gentamicin resistance cassette in a pUC18-derived plasmid
(pMP016) at the SacI/MluI and SacII/PstI restriction sites, respectively.
The resulting suicide vector was confirmed by sequencing and designated
pMP007. The pMP007 plasmid DNA was then transformed into an infec-
tious clone of B. burgdorferi strain 297, AH130 (37). Gentamicin-resistant
transformants were analyzed by PCR, reverse transcription (RT)-PCR,
and immunoblotting to confirm the loss of bb0104. Endogenous plasmid
profiles of the bb0104 mutant clones were determined by PCR on the basis
of recently published sequences (10). Two clones with a plasmid profile
identical to that of AH130 were chosen for further study.
For genetic complementation of the BbhtrA mutant, we used B. burg-
dorferi shuttle plasmid pBSV2-derived shuttle vector pYY003 (38) to de-
liver the wild-type (WT) copy of the BbhtrA gene. Since the intergenic
region upstream region of the BbhtrA open reading frame (ORF) does not
seem to harbor a discernible promoter region, we fused the BbhtrA ORF
with the B. burgdorferi flaB promoter. The DNA fragment encompassing
the BbhtrA gene downstream of the flaB promoter was cloned into the
NdeI and BglII sites of pYY003. About 10g of the recombinant plasmid,
designated pXW003, was electroporated into the BbhtrA-deficient B.
burgdorferi strain, and complemented clones were selected with 350
g/ml kanamycin in the growth medium. PCR analyses were further per-
formed to confirm that the BbhtrA-complemented clones retained the
same plasmid profile as the WT spirochetes.
Our repeated attempts to attain stable in cis complementation of
BbhtrA isolates were unsuccessful. Therefore, the above-mentioned
BbhtrA-complemented isolate, which contained a WT copy of the BbhtrA
gene in the shuttle plasmid, was used in all in vitro studies in the presence
of kanamycin. For phenotypic analysis in vivo, two isogenic and indepen-
dent BbhtrA mutant clones (designated M1 and M2) were included in all
of our experiments.
Western and far-Western blotting. Immunoblotting assays were per-
formed by standard procedures as detailed elsewhere (28). Briefly, whole-
cell lysates of B. burgdorferi grown in BSK-II medium at 34°C and 37°C
were resolved by SDS-PAGE, transferred to a nitrocellulose membrane,
and probed with anti-BB0323 (1:3,000), anti-BB0238 (1:3,000), anti-
BB0365 (1:1,000), and anti-BbHtrA (1:3,000) antibodies (28, 39). Immu-
noblot assays were developed by the addition of horseradish peroxidase
(HRP)-conjugated secondary antibodies (1:5,000 to 10,000) and en-
hanced chemiluminescence as previously described (28). For far-Western
analyses, the nitrocellulose membrane was incubated with His-BB0323 (2
g) overnight at 4°C in blocking buffer (2% skim milk in Tris-buffered
saline, pH 7.5, with 0.05% Tween 20) and washed with Tris-buffered
saline with Tween 20, and bound proteins were detected by immunoblot-
ting with an anti-BB0323 antibody and an HRP-conjugated secondary
antibody. Quantitative densitometry was performed with ImageJ software
(NIH).
PCR assays. The primers used in PCR and quantitative RT-PCR
(qRT-PCR) assays are shown in Table S1 in the supplemental material.
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Total RNA from in vitro-grown B. burgdorferi or from infected mouse
tissues was isolated with TRIzol reagent (Invitrogen), treated with DNase
I (NEB), reverse transcribed to cDNA (SuperScript VILO; Invitrogen),
and analyzed by real-time PCR with iQ SYBR green Supermix (Roche
Diagnostics) as detailed previously (40). For quantitative analysis of gene
expression, the target transcripts were normalized to the number of flaB
transcripts, whereas for quantitative measurement of B. burgdorferi bur-
dens in infected tissues,flaB transcripts were normalized to mouse-actin
levels as previously detailed (40).
Growth analysis of spirochetes. WT, BbhtrA mutant, and comple-
mented spirochetes were assessed for growth in vitro and further analyzed
by electron microscopy. Spirochetes were grown at 34°C in BSK-II me-
dium containing 6% rabbit serum to early log phase and repassaged (105
spirochetes/ml) into new medium. The spirochetes were cultivated in
triplicate at 34°C and 37°C and counted every 24 h with a Petroff-Hausser
cell counter (Fisher Scientific) under a dark-field microscope as previ-
ously detailed (41).
Electron microscopy. Electron microscopic analyses were performed
as previously detailed (42), with minor modifications. The WT, BbhtrA
deletion mutant, and complemented strains were grown at 34°C or 37°C
to a density of 107 cells/ml. For transmission electron microscopy, spiro-
chetes were washed four times with phosphate-buffered saline (PBS) and
fixed in 2% glutaraldehyde–PBS for 60 min, followed by 1% osmium
tetroxide for 30 min, at room temperature. The samples were dehydrated,
embedded, sectioned, and then collected on copper grids. Samples were
poststained with 2.5% uranyl acetate and lead citrate and finally analyzed
with two transmission electron microscopes (Zeiss 10CA and JEOL
100CXII). Scanning electron microscopy was performed by a similar pro-
cedure, except that the samples were subjected to critical-point drying
with liquid carbon dioxide after the dehydration step. Dried samples were
mounted on stubs coated with a gold-palladium alloy and analyzed under
a scanning electron microscope (Hitachi S-4700).
Infection studies. Groups of three C3H/HeN mice were injected in-
tradermally with the same number (105 cells/per mouse) of WT spiro-
chetes or two independent clones of BbhtrA-deficient spirochetes (desig-
nated M1 and M2). Samples of skin, heart, and bladder were isolated at 14
days after infection, and B. burgdorferi levels were assessed by qRT-PCR
analysis of flaB transcripts normalized to murine -actin levels as de-
scribed previously (40). Additionally, skin and spleen tissues were cul-
tured in BSK-II medium and analyzed weekly for 4 weeks with a dark-field
microscope (43).
Statistical analysis. Results are expressed as the mean the standard
error of the mean (SEM). The statistical significance of differences ob-
served between experimental and control groups was analyzed with
GraphPad Prism version 4.0 (GraphPad Software, CA). Student’s t test
was used to compare the mean values, and P 0.05 was considered sta-
tistically significant.
RESULTS
BbHtrA is a conserved spirochete protein induced in the sta-
tionary growthphase andat elevated temperatures.The primary
sequence of BbHtrA, which possesses typical serine protease ac-
tivity (28–32), is highly conserved within diverse B. burgdorferi
sensu lato strains. To further confirm the conservation of BbHtrA
and to assess whether diverse isolates and strains of the species B.
burgdorferi sensu lato produce HtrA orthologs, whole-cell lysates
from different strains were probed with BbHtrA antibody raised
against isolate B31. As shown in Fig. 1A (top), an antibody raised
against isolate B31 recognized HtrA orthologs in all of the strains,
which produced the antigen at comparable levels. As HtrA belongs
to a family of proteases that are activated under various stress
conditions, including high temperature, we examined the levels of
BbhtrA expression at different temperatures and in different
phases of growth. B. burgdorferi bacteria were cultured at the op-
timal laboratory growth temperature (34°C) or at an elevated,
mammal-specific temperature (37°C). Samples were collected in
the early (105 cells/ml) and late (108 cells/ml) growth phases and
processed for assessment of BbhtrA transcript and protein levels
by qRT-PCR and immunoblotting, respectively. Notably, as
shown in Fig. 1B, BbhtrA transcripts were more abundant in the
stationary phase than in the early growth phase, irrespective of the
culture temperature. There was also an overall higher BbhtrA
transcript level at 37°C than at 34°C, especially in the late phase of
growth. To further confirm whether increased mRNA levels also
resulted in an increase in corresponding protein expression levels,
samples from the different growth phases were subjected to im-
munoblotting with anti-BbHtrA antiserum. In accordance with
the transcript level, BbHtrA protein levels were higher in the sta-
tionary phase (Fig. 1C and D) than in the early growth phase,
while the level of FlaB remained constant throughout the growth
of spirochetes in vitro. Taken together, these data suggest that the
expression of BbhtrA is induced under various stress conditions,
such as higher temperatures, as mimicked by growth at 37°C and
spirochete growth in the stationary phase.
BbHtrA deficiency results in impairment of spirochete
growth and cellular organization at a mammalian-phase-spe-
cific temperature. Previous attempts by several groups to gen-
erate a BbhtrA deletion mutant of B. burgdorferi were unsuc-
cessful (28–32). This observation, together with the occurrence
of BbhtrA as a single-copy gene in the spirochete genome, led to
speculation that BbHtrA is likely involved in an essential
housekeeping function and thus attempts to delete it would
incur a lethal mutation. However, unlike our previous mutagen-
esis attempts involving the B. burgdorferi B31 isolate, we were
successful in generating a BbhtrA deletion mutant of infectious
and low-passage-number 297 isolate AH130 (37). The mutant was
generated by replacing the ORF of BbhtrA (bb0104) with the gen-
tamicin resistance cassette via homologous recombination as il-
lustrated in Fig. 2A. Two independent gentamicin-resistant clones
(designated M1 and M2) with the same endogenous plasmid pro-
file as AH130 were used for subsequent analysis. The desired in-
tegration was confirmed by amplification of the product in mu-
tants with primers specific to the antibiotic resistance gene, as
opposed to the WT (Fig. 2B). qRT-PCR analysis confirmed the
absence of a BbhtrA transcript in the mutants and its restoration in
the complemented strain (Fig. 2C) and ruled out the polar effects
of mutation on adjacent transcripts bb0103 and bb0105, which
were expressed at levels similar to those of the WT. Finally, the loss
of the BbHtrA protein was verified by immunoblotting whole-cell
extracts from WT and mutant spirochetes with anti-BbHtrA an-
tibody (Fig. 2E). To rule out the possibility of anomalous effects of
genetic manipulation, we sought to complement the BbhtrA-de-
ficient B. burgdorferi strain with a WT copy of the BbhtrA gene in
cis. As the BbhtrA gene lacks an obvious upstream promoter and is
probably part of an operon, we fused the ORF of BbhtrA with the
B. burgdorferi flaB promoter. Although our exhaustive efforts to
generate a stable and cis-complemented strain were unsuccessful,
we were able to complement, in trans via a shuttle plasmid, the
BbhtrA-deficient spirochetes with a WT copy of the gene under
the control of the flaB promoter (Fig. 2D), which restored the
production of BbHtrA in the complemented isolate (Fig. 2E).
To assess the role of BbHtrA in the growth of B. burgdorferi,
WT, BbhtrA mutant, and complemented spirochetes were cul-
tured at laboratory (34°C) and elevated (37°C) temperatures. As
Ye et al.
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shown in Fig. 3A, the BbhtrA mutant grew comparably to the WT
at 34°C but exhibited a slow-growth phenotype at 37°C (Fig.
3A) and formed unusually large clumps at all cell densities.
Notably, the mutant isolates regained their normal morphol-
ogy when shifted back to 34°C either during early log phase or
following inoculation into fresh medium (data not shown).
Unlike the BbhtrA mutant, the complemented isolate displayed a
growth pattern similar to that of WT spirochetes, indicating that
the defect was specific to the deletion of BbhtrA (Fig. 3A). These
data also suggest that BbHtrA might not be essential for spirochete
growth in vitro at 34°C but is important for maintaining normal
cell growth and morphology at elevated temperatures.
Scanning and transmission electron microscopic studies re-
vealed that the loss of BbhtrA results in striking alterations in
cellular organization when spirochetes are grown at 37°C. In con-
trast to WT organisms that grew as single replicating cells, BbhtrA
mutant organisms appeared as clumped cells or intertwined
masses with spherical blebs (Fig. 3B). While the WT and comple-
mented spirochetes showed distinct outer and inner membrane
sandwiching the periplasmic space harboring flagella, BbhtrA mu-
tant spirochetes exhibited several large, predominantly membra-
nous, irregularly shaped, hollow structures containing round ves-
icles, protoplasmic cylinders revealing flagella beneath the outer
membrane (Fig. 3B).
BbHtrA function is critical for infection ofmice. To examine
the role of BbHtrA in infectivity, separate groups of C3H/HeN
mice were inoculated intradermally with WT and genetically ma-
nipulated spirochetes (105 cells/mouse). As our complemented
isolate was generated with a shuttle plasmid that uses the antibi-
otic kanamycin, which has a shorter half-life in mice, this isolate
cannot be used for in vivo infection studies. In fact, our efforts to
maintain the shuttle plasmid in mice via intermittent administra-
tion of various doses of the antibiotic remained unsuccessful, per-
haps because of faster clearance or an insufficient concentration of
kanamycin in vivo. Therefore, for the infection studies, we used
two independent BbhtrA mutant clones, designated M1 and M2.
Samples of skin, heart, bladder, and serum were collected at day 14
and tested for B. burgdorferi infection by serology, qRT-PCR, and
culture. As shown in Fig. 4A, unlike the WT, which showed a
strong serological response, both of the mutants had a severely
FIG 1 BbHtrA is conserved in infectious B. burgdorferi sensu lato isolates and highly expressed in the stationary phase or at an elevated temperature. (A)
Production of BbHtrA in representative isolates of infectious B. burgdorferi sensu lato. Whole-cell extracts from B. burgdorferi isolates B31, 297, and N40; B. afzelii
isolate PKo; and B. garinii isolate PBi were immunoblotted with BbHtrA antiserum generated against the recombinant HtrA protein of B. burgdorferi B31. The
expression of FlaB in different isolates is shown at the bottom. (B) BbhtrA is induced in the stationary growth phase and at an elevated temperature. Spirochetes
were grown at 34°C (left) and 37°C (right), and samples were harvested in the growth (105 cells/ml) and stationary (108 cells/ml) phases. The BbhtrA transcript
level was measured by qRT-PCR and normalized to the number of copies of the flaB transcript. The bars represent the mean values of three independent
experiments, and the error bars represent the SEM. The levels of BbhtrA mRNA are elevated in the stationary phase and at 37°C. *, P 0.05. (C) BbHtrA protein
expression levels in the log and stationary growth phases of spirochetes in culture. Bacterial lysates at the growth phases and temperatures indicated were either
assessed by Ponceau S staining (top) or subjected to immunoblotting with anti-BbHtrA (middle) and anti-FlaB (bottom) antisera. (D) Levels of BbHtrA relative
to FlaB from panel C were determined by quantitative densitometry. The levels of BbHtrA are increased in the stationary phase. *, P 0.05.
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attenuated ability to induce an antibody response to spirochete
proteins, suggesting their clearance during early mammalian in-
fection. The qRT-PCR analyses further revealed that BbhtrA mu-
tant clones were undetectable in all of the tissues tested (Fig. 4B).
Finally, culture analysis confirmed that the BbhtrA mutants re-
mained undetectable in the samples collected from all six mice
infected with either of the two mutant clones, whereas WT spiro-
chetes could be readily detected in corresponding mice (see Table
S2 in the supplemental material). Together, studies described
above suggest an essential role for BbHtrA in the establishment of
B. burgdorferi infection in murine hosts.
The borrelial protein BB0323 is processed by BbHtrA. We
previously demonstrated that BbHtrA cleaves BB0323, one of the
proteins required for infectivity, in a manner dependent upon its
catalytic serine residue (28). The BB0323 protein is required for
normal organization of the outer membrane, cell fission, persis-
tence in mice, and the transition between the host and the vector
in vivo (34). Recent in vitro studies using recombinant BbHtrA
have led to the identification of additional substrates that include
borrelial virulence determinants like P66 and host proteins that
are important for infectivity or pathogenesis (28–32). Specifically,
our previous studies suggest that recombinant BbHtrA interacts
with and specifically cleaves BB0323 into a larger N-terminal poly-
peptide and a shorter C-terminal polypeptide (28). As morpho-
logical abnormalities and the defect in virulence exhibited by
BbHtrA are analogous to those of BB0323 deletion mutants (34),
we sought to confirm whether maturation of BB0323 is dysregu-
lated in the absence of BbHtrA. To test this, we measured the
BB0323 mRNA and protein levels in the BbhtrA mutant and com-
plemented isolates. As shown in Fig. 5A, no discernible difference
in the BB0323 transcript or protein levels of the WT, BbhtrA mu-
tant, and complemented strains were noted at 34°C. Interestingly,
a less BB0323 protein expression was noticed in BbhtrA mutant
clones than in the WT or complemented strain at 37°C (Fig. 5B).
Our earlier studies suggested that the immature full-length
BB0323 protein and its mature C-terminal polypeptide are diffi-
cult to detect in B. burgdorferi by conventional immunoblotting
assays with anti-BB0323 antibodies, most likely because of their
lower stability or rate of occurrence; however, they can be detected
by a far-Western assay with the BB0323 N-terminal polypeptide
that binds the C-terminal polypeptide (28). Using the latter ap-
proach, we detected full-length BB0323 in the BbhtrA mutant iso-
lates, which was absent from the WT at 37°C (Fig. 5C). The ex-
pression of full-length BB0323 was significantly reduced in the
complemented strain, further suggesting that the processing of
full-length BB0323 is impaired in the absence of BbHtrA. It has
previously been established that BB0323 interacts with another
virulence determinant, BB0238, and regulates its expression in B.
burgdorferi (44). In order to test whether BbHtrA regulates
BB0323 via BB0238, we monitored the level of BB0238 expression
in the BbhtrA mutant. As shown in Fig. 5D, BbHtrA-deficient
spirochetes expressed BB0238 at a level similar to that of the WT
or complemented strain at the elevated mammalian host-specific
(37°C) temperature, further suggesting the specificity of BB0323
processing by BbHtrA.
FIG 2 Construction and analysis of bb0104 (BbhtrA) mutant and complemented strains. (A) Schematic representation of WT and BbhtrA mutant isolates (M1
and M2) at the bb0104 (hrtA_Bb) locus of B. burgdorferi 297. The bb0103, bb0104, and bb0105 genes and the gentamicin cassette (aacC1) replacing the native
bb0104 ORF are indicated. (B) Integration of the gentamicin resistance cassette at the intended locus in the genome. Primer pairs P1-P2, P4-P5, and P3-P6 were
used to amplify the native bb0104 gene and the inserted gentamicin cassette at the bb0104 locus, respectively. PCR was performed with the genomic DNA of WT
(lanes W) and mutant (lanes M) B. burgdorferi, and the amplified products were checked on a 1% agarose gel. The migration of a DNA molecular size ladder is
shown in the leftmost and rightmost lanes. (C) qRT-PCR analysis of BbhtrA deletion and complementation and polar effects on cognate bb0103 and bb0105
transcripts. Total RNA was isolated from WT, mutant (M1), and complemented (Com) B. burgdorferi, converted to cDNA, and further used to amplify the
regions with BbhtrA and the adjacent bb0103 and bb0105 genes. The amplified products were visualized on a 1% agarose gel. (D) Diagram of the shuttle vector
pXW003 used for complementation. pXW003 is a pBSV2-derived shuttle vector carrying the bb0104 gene under the control of the flaB promoter. (E) Protein
expression analyses of WT, BbhtrA mutant (M1 and M2), and complemented (Com) B. burgdorferi. Equal amounts of bacterial extracts were subjected to
SDS-PAGE, transferred to a membrane, and immunoblotted with anti-BbHtrA (top) and anti-FlaB (bottom) antisera.
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DISCUSSION
HtrA proteins are generally involved in cellular adaptation to var-
ious stress response events via their protease and chaperone func-
tions, maintaining tight protein quality control in organisms, in-
cluding microbes (12). These proteases-chaperones function in an
ATP-independent manner; therefore, many prokaryotic and eu-
karyotic genomes encode multiple homologs of these highly effi-
cient proteins that are involved in diverse cellular functions (12,
13). Interestingly, HtrA has been shown to play an important role
in the pathogenesis of several Gram-positive, as well as Gram-
negative, bacteria (27, 45). Owing to their important roles in cel-
lular physiology, several pathogens harbor multiple homologs of
HtrA. However, B. burgdorferi encodes a single HtrA, termed
BbHtrA, which is pivotal in the establishment of infection in the
mammalian host. Recent studies have suggested that BbHtrA is
responsible for the proteolytic processing of a number of key vir-
ulence determinants, such as BB0323, P66, BmpD, and CheX (31),
indicating its role in diverse cellular processes. For instance, the
cleavage of the phosphatase CheX by BbHtrA suggests that it has a
role in regulating bacterial motility and chemotaxis, the key cellu-
lar processes that contribute to the invasiveness of B. burgdorferi
and play important roles in the progression of the disease (29). On
the other hand, the identification of outer membrane proteins
such as BB0323, P66, and BmpD as the substrates of BbHtrA im-
plies that it has a role in the regulation of key virulence determi-
nants that are important for the biogenesis or organization of the
membrane, transport across the membrane, or host-pathogen in-
teraction (28–30). Although studies using B. burgdorferi stains
overexpressing BbhtrA have shed new light on the function of the
protease it encodes and its potential roles in virulence, previous
efforts to generate BbhtrA deletion mutants have been unsuccess-
ful (28–30), which has also limited our understanding of its role in
spirochetal biology and infection. The study described here shows
that the successful deletion of BbhtrA in low-passage-number
strain 297 of B. burgdorferi results in a severely distorted morphol-
ogy of the spirochetes at elevated temperatures, thereby attenuat-
ing their ability to infect mice. The aberrant cell morphology of
BbhtrA mutants grown at the higher, mammalian host-specific
temperature included striking alterations in their cellular struc-
tures and occasional fission defects, as well as the formation of
blebs within a nearly round sac-like structure. The restoration of
normal morphology upon the reintroduction of the gene in trans
further reinforced the idea that the effect was specifically mediated
by BbHtrA. Similar structurally heterogeneous entities have pre-
viously been recorded and are known to occur in spirochete pop-
ulations that encounter stress, such as in unfed ticks or upon ex-
posure to borreliacidal agents (46–49). Here, we propose a critical
role for BbHtrA, a high-temperature-induced protease, in the cel-
lular regulation and stress tolerance of Lyme disease spirochetes. A
similar high-temperature sensitivity of HtrA deletion mutants has
FIG 3 Growth and morphological analysis of WT and genetically manipulated spirochetes in vitro. (A) WT, BbhtrA mutant (M1), and complemented (Com)
spirochetes were diluted to a density of 105/ml, grown at either 34°C (top) or 37°C (bottom) in BSK-H medium, and counted under a dark-field microscope every
24 h with a Petroff-Hausser cell counter. Note that BbhtrA mutant isolates grew as single cells in the early growth phase but started forming clumps in the late
growth phase at 37°C. (B) Morphological analysis of WT, BbhtrA mutant, and complemented B. burgdorferi isolates. On the left is a scanning electron
microscopic (SEM) analysis of spirochetes grown at 37°C. Masses of intertwined spirochetes and spherical blebs (arrows) are visible. On the right are transmission
electron micrographs (TEM) of Epon-embedded spirochetes. Note the presence of large, nearly round structures enclosing two or more cells (arrow) in the
mutant.
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also been observed in other organisms such as Escherichia coli and
Saccharomyces cerevisiae (50, 51). Interestingly, despite the pres-
ence of BbhtrA as a single gene, the generation of deletion mutants
with growth kinetics similar to those of WT spirochetes, especially
at 34°C, suggests that its role is nonessential, at least in the in vitro
growth of the organism.
While determination of the precise cellular function of BbHtrA
awaits future studies, genetic manipulation of its expression in B.
burgdorferi affected the levels of several spirochete proteins, such
as P66 (30) and BB0323, but not those of several other proteins
tested, suggesting that the protease is involved in the regulation of
a specific set of borrelial proteins performing diverse functions in
spirochete biology. As both the transcript levels and posttransla-
tional maturation of target proteins are affected by BbhtrA defi-
ciency or overexpression, as shown for BB0323 and P66 (30), it is
likely that this protein could affect the processing of an unknown
gene regulator, as speculated earlier (30). Additionally, BbHtrA
could also act as a chaperone by providing an extended protein
conformation in the periplasm before folding and insertion into
the membrane or may promote the degradation of misfolded pro-
teins prior to translocation in the membrane (12, 13). These ob-
servations are supported by the localization of BbHtrA in the var-
ious cellular compartments, including the periplasmic fraction, of
B. burgdorferi (28). Apart from its role in the intracellular regula-
tion of spirochete proteins, the secreted form of BbHtrA, which is
potentially released into the mammalian host during infection
and degrades the host extracellular matrix and proteoglycan (32),
is directly involved in host infection and pathogenesis. One caveat
regarding our study is that we did not perform infection experi-
ments with the trans-complemented clone. However, two inde-
pendent mutants that have all of the plasmids described here
showed the same phenotype, strongly indicating that the BbHtrA-
deficient spirochete is not infectious. While the precise reason why
BbhtrA mutants lost virulence in mammalian hosts remains enig-
matic, we speculate that multiple mechanisms could be responsi-
ble. To persist in a higher-temperature environment such as a
mammalian host, spirochetes would require the critical functional
support of BbHtrA, the absence of which renders mutants im-
paired for optimal growth and successful dissemination through
host tissues.
Previously, we identified a virulence determinant, BB0323,
that plays an important role in infectivity (34), possibly because of
its critical involvement in spirochete fission and outer membrane
integrity (33, 34), including other unknown functions. The re-
combinant form of BbHtrA specifically cleaved BB0323 into N-
and C-terminal polypeptides with sizes that roughly corre-
sponded to the mature polypeptides in spirochetes, suggesting
that BB0323 is the specific substrate of BbHtrA (28). These initial
results and the similarity of the morphological aberrations associ-
ated with the deletion of both BB0323 (34) and BbHtrA in the
present study underscore the important role of the protease in the
processing of BB0323 in B. burgdorferi. Interestingly, we not only
noticed a reduction in cleaved and mature BB0323 but also de-
tected uncleaved BB0323 in the BbhtrA deletion mutant at 37°C,
which was further reduced upon complementation of the gene in
trans. The processing of BB0323 remains unaffected at the normal
growth temperature (34°C), raising the possibility that another
cleavage mechanism or an unknown protease with a function sim-
ilar to that of BbHtrA exists in spirochetes. It is noteworthy that
the C-terminal protease CtpA also plays a role in the final process-
ing of BB0323 polypeptides (52), and therefore, it might be possi-
ble that multiple proteases cleave BB0323 at the various tempera-
tures and environments the spirochetes encounter in mammals
and in the arthropod vector. At least two mechanisms could be
FIG 4 BbhtrA is required for infection of mice. (A) Immunoreactive profiles of mice infected with WT and BbhtrA mutant spirochetes. Groups of three
C3H/HeN mice were infected with WT and BbhtrA mutant isolates (M1 and M2). Serum samples collected 2 weeks postinoculation were used to screen an
immunoblot of B. burgdorferi cell lysate. (B) Spirochete burdens in infected mice were assessed by qRT-PCR by measuring the number of copies of the B.
burgdorferi flaB gene normalized to mouse -actin levels in the skin, heart, and bladder. Error bars represent the SEM of three independent experiments. BbhtrA
mutants M1 and M2 remained undetectable in the murine tissues tested.
Ye et al.
2378 iai.asm.org August 2016 Volume 84 Number 8Infection and Immunity
attributed to the role of BbHtrA in the processing of BB0323 at the
mammal-specific temperature. First, BbHtrA directly processes
BB0323, and precise cleavage of BB0323 might be essential for cell
fission or infectivity; therefore, absence of BbHtrA results in accu-
mulation of the uncleaved polypeptide, leading to altered cell
morphology, as seen in BbhtrA deletion mutants, and subsequent
loss of virulence. Second, BbHtrA might act as a chaperone for the
cleaved N terminus, and the loss of BbHtrA increased the suscep-
tibility of the N terminus to degradation, thereby resulting in a
defect in fission and hence infectivity. At this point, it cannot be
confirmed that the reduction in the processed or cleaved BB0323
polypeptide was due to its increased susceptibility to degradation
in the absence of BbHtrA at the elevated temperature or to im-
paired cleavage of the full-length protein. Nevertheless, our data
strongly argue that BbHtrA is involved in the processing and reg-
ulation of BB0323 in B. burgdorferi, especially at an elevated,
mammalian host-specific temperature.
In summary, we demonstrated that targeted deletion of BbhtrA
results in specific spirochete phenotypes, preferentially at an ele-
vated temperature, including slower growth, altered morphology
and cellular architecture, and attenuated infection of mice. Al-
though the loss of virulence could not be reversed in the comple-
mented isolate because of technical constraints, most of the de-
fects exhibited by BbhtrA mutants in vitro can be cured by the
introduction of a copy of the gene in trans. The transcription and
posttranslational processing of at least one key virulence determi-
nant, BB0323, are also affected. These studies open a new line of
investigation in understanding the regulation of proteins involved
in key cellular processes and infection by BbHtrA. Further studies
are warranted to investigate the role of BbHtrA in the tick phase of
the cycle of B. burgdorferi and further elucidate its involvement in
the global regulation of important cellular proteins.
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